Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) [0.03%]
前言：2017年银屑病和银屑病关节炎研究与评估小组（GRAPPA）年会
Philip S Helliwell,Dafna D Gladman,Alice B Gottlieb
Philip S Helliwell
The 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) was held in Amsterdam, the Netherlands, and was attended by rheumatologists, dermatologists, representatives of biopharmaceutical...
Guido Valesini,Ignazio Olivieri
Guido Valesini
Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis [0.03%]
肿瘤坏死因子抑制剂以外的药物在银屑病关节炎治疗中的作用
Fabiola Atzeni,Luisa Costa,Francesco Caso et al.
Fabiola Atzeni et al.
Psoriatic arthritis (PsA) is a systemic inflammatory disease characterized by possible peripheral and axial joint involvement, enthesitis, dactylitis, and skin and nail disease. It affects up to one-third of psoriatic patients, and may be a...
The Role of Tumor Necrosis Factor-α Blockers in Psoriatic Disease. Therapeutic Options in Psoriatic Arthritis [0.03%]
肿瘤坏死因子α拮抗剂在银屑病中的作用。银屑病关节炎的治疗选择
Olga Addimanda,Niccolò Possemato,Andrea Caruso et al.
Olga Addimanda et al.
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting peripheral and axial joints, usually associated with psoriasis (PsO) and involving various systems and organs (eye inflammation, such as uveitis; and involvement of nail ...
New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol [0.03%]
用于治疗银屑病关节炎的肿瘤坏死因子抗原的新方法： certolizumab pegol的应用
Alberto Cauli,Matteo Piga,Ennio Lubrano et al.
Alberto Cauli et al.
The pathogenesis of psoriatic arthritis (PsA) is still under discussion but great advances have been made in the last 2 decades that confirm the central role of tumor necrosis factor-α (TNF-α) in its inflammatory milieu. New therapeutic a...
Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement [0.03%]
用于治疗具有轴向受累的脊柱关节炎和银屑病关节炎患者的传统疾病修饰抗风湿药物(DMARD)及其联合治疗的效果研究
Davide Simone,Marcin Nowik,Elisa Gremese et al.
Davide Simone et al.
Treatment with nonsteroidal antiinflammatory drugs (NSAID) is the recommended first-line therapy in patients with axial spondyloarthritis (axSpA); and for those patients who have persistently active disease, the introduction of tumor necros...
Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs [0.03%]
银屑病性关节炎：传统抗风湿药治疗进展
Antonio Marchesoni,Ennio Lubrano,Alberto Cauli et al.
Antonio Marchesoni et al.
We present an update on the effects of methotrexate (MTX), sulfasalazine (SSZ), leflunomide (LEF), and cyclosporine (CSA) in psoriatic arthritis (PsA) by reviewing data published from January 2010 to June 2014. The most relevant study on MT...
Paolo Gisondi,Marco Di Mercurio,Luca Idolazzi et al.
Paolo Gisondi et al.
Psoriasis is a lifelong chronic inflammatory disease affecting 2-3% of the worldwide population. Current understanding of the pathogenesis of psoriasis assigns central importance to an interaction between acquired and innate immunity. The d...
Imaging Techniques in Psoriatic Arthritis: Update 2012-2014 on Current Status and Future Prospects [0.03%]
银屑病关节炎的影像技术：2012-2014年当前进展及未来前景更新
Elena Aleo,Stefania Migone,Valentina Prono et al.
Elena Aleo et al.
By providing additional and more sensitive information over clinical examination, imaging techniques are useful in the assessment of patients with psoriatic arthritis (PsA) and have been increasingly used to obtain additional clues to its p...
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints [0.03%]
银屑病关节炎滑膜组织中T淋巴细胞的体外信号转导蛋白定位研究
Ugo Fiocco,Veronica Martini,Benedetta Accordi et al.
Ugo Fiocco et al.
We assessed signaling protein mapping in total T cells, to analyze the proportions of T regulatory (Treg) and TCD4+ effector (Teff) cell phenotypes, and the respective interleukin 6Rα (IL-6Rα) expression in the inflammatory microenvironme...